Morgan Stanley
RVMDW icon

Morgan Stanley’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Morgan Stanley’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.8K Hold
2,216
– – ﹤0.01% 6805
2026
Q1 		$3.97K Buy
+2,216
New +$4.29K ﹤0.01% 7200

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Morgan Stanley's RVMDW Position: Q2 2026 in Review

Morgan Stanley held its Revolution Medicines Inc Warrant (RVMDW) position steady in Q2 2026 at 2,216 shares worth $20.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6805.

Morgan Stanley first reported a position in RVMDW in Q1 2026 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

  • Morgan Stanley held 2,216 shares of Revolution Medicines Inc Warrant worth $20.8K as of Q2 2026.
  • Morgan Stanley left its Revolution Medicines Inc Warrant share count unchanged in Q2 2026.
  • Revolution Medicines Inc Warrant made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6805 holding.
  • Morgan Stanley first reported a position in Revolution Medicines Inc Warrant in Q1 2026 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.